New data from Novo Nordisk’s phase 3 trial of an oral, high-dose formulation of semaglutide reinforces its potential as a weight-loss therapy in obesity, but Eli Lilly is in hot pursuit. The 50 ...

En 21-årig mand fra Gentofte blev kørt mod hospitalet i kritisk tilstand efter en faldskærmsulykke tidligere i dag ved ...

Politiet var fredag aften talstærkt til stede i forbindelse med et stort slagsmål ved et bowlingcenter i Slagelse.

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...

Drugmaker Novo Nordisk said it is halting its agreement with telehealth company Hims & Hers after less than two months, ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Omnicom's $13.5 billion acquisition of rival Interpublic can move forward on the condition the new company does not enter ...

Novo Nordisk ends partnership with Hims & Hers over compounded Wegovy, shaking the market. See why I recommend a wait-and-see ...

Novo Nordisk trækker stikket på et samarbejde med kontroversiel amerikansk partner efter knapt to måneder. Årsagen er ifølge ...

Novo Nordisk is likely to draw investor attention on Monday after the company said it is moving forward with the oral and ...